Drug Patent Expirations in May 2010
Drug Patent Expirations in May 2010
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
|---|---|---|---|---|
| ZOLOFT | Pfizer | sertraline hydrochloride | 4,962,128*PED | May 2, 2010 |
| ARTHROTEC | Gd Searle Llc | diclofenac sodium; misoprostol | 5,698,225 | May 3, 2010 |
| FEMHRT | Warner Chilcott | ethinyl estradiol; norethindrone acetate | 5,208,225 | May 4, 2010 |
| LANTUS | Sanofi Aventis Us | insulin glargine recombinant | 6,100,376*PED | May 6, 2010 |
| EPZICOM | Viiv Hlthcare | abacavir sulfate; lamivudine | 5,047,407*PED | May 17, 2010 |
| ETOPOPHOS PRESERVATIVE FREE | Bristol Myers Squibb | etoposide phosphate | RE35524 | May 17, 2010 |
| EPIVIR | Viiv Hlthcare | lamivudine | 5,047,407*PED | May 17, 2010 |
| COMBIVIR | Viiv Hlthcare | lamivudine; zidovudine | 5,047,407*PED | May 17, 2010 |
| IPRIVASK | Canyon | desirudin recombinant | 4,745,177 | May 17, 2010 |
| TRIZIVIR | Viiv Hlthcare | abacavir sulfate; lamivudine; zidovudine | 5,047,407*PED | May 17, 2010 |
| EPIVIR-HBV | Glaxosmithkline | lamivudine | 5,047,407*PED | May 17, 2010 |
| RESCULA | Sucampo Pharms | unoprostone isopropyl | 5,212,200 | May 18, 2010 |
| LEVULAN | Dusa | aminolevulinic acid hydrochloride | 5,211,938 | May 18, 2010 |
| RESTORIL | Tyco Hlthcare | temazepam | 5,211,954 | May 18, 2010 |
| IOPIDINE | Alcon | apraclonidine hydrochloride | 5,212,196 | May 18, 2010 |
| VISUDYNE | Qlt | verteporfin | 5,214,036 | May 25, 2010 |
| DIFFERIN | Galderma Labs Lp | adapalene | 4,717,720 | May 31, 2010 |
| EPIDUO | Galderma Labs | adapalene; benzoyl peroxide | 4,717,720 | May 31, 2010 |
| DIFFERIN | Galderma Labs Lp | adapalene | RE34440 | May 31, 2010 |
| EPIDUO | Galderma Labs | adapalene; benzoyl peroxide | RE34440 | May 31, 2010 |
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.Courtesy of DrugPatentWatch.com



















Leave a Reply
Want to join the discussion?Feel free to contribute!